ThinkEquity says that its channel checks show the spine market remains stable despite the challenging environment, and that Nuvasive (NUVA -0.7%) is poised to beat Q2 Street estimates. The firm ups its price target to $30 from $25 and reiterates a Buy.
ThinkEquity says that its channel checks show the spine market remains stable despite the...
From other sites
Video at CNBC.com (Jul 13, 2016)
Video at CNBC.com (Jun 3, 2016)
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs